Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 4
1966 13
1967 18
1968 18
1969 31
1970 30
1971 33
1972 25
1973 37
1974 25
1975 28
1976 27
1977 49
1978 45
1979 46
1980 44
1981 57
1982 81
1983 111
1984 158
1985 150
1986 112
1987 127
1988 144
1989 164
1990 176
1991 112
1992 163
1993 113
1994 137
1995 119
1996 123
1997 128
1998 106
1999 130
2000 154
2001 164
2002 193
2003 178
2004 188
2005 204
2006 233
2007 239
2008 228
2009 272
2010 292
2011 305
2012 322
2013 394
2014 396
2015 390
2016 369
2017 330
2018 385
2019 404
2020 500
2021 712
2022 712
2023 630
2024 223

Text availability

Article attribute

Article type

Publication date

Search Results

10,099 results

Results by year

Filters applied: . Clear all
Page 1
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma.
Rosenberg JE, Powles T, Sonpavde GP, Loriot Y, Duran I, Lee JL, Matsubara N, Vulsteke C, Castellano D, Mamtani R, Wu C, Matsangou M, Campbell M, Petrylak DP. Rosenberg JE, et al. Ann Oncol. 2023 Nov;34(11):1047-1054. doi: 10.1016/j.annonc.2023.08.016. Epub 2023 Sep 9. Ann Oncol. 2023. PMID: 37678672 Clinical Trial.
Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up.
Powles T, Park SH, Caserta C, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Sternberg CN, Bellmunt J, Aragon-Ching JB, Wang J, Huang B, Laliberte RJ, di Pietro A, Grivas P. Powles T, et al. J Clin Oncol. 2023 Jul 1;41(19):3486-3492. doi: 10.1200/JCO.22.01792. Epub 2023 Apr 18. J Clin Oncol. 2023. PMID: 37071838 Free PMC article. Clinical Trial.
The androgen receptor in bladder cancer.
Chen J, Huang CP, Quan C, Zu X, Ou Z, Tsai YC, Messing E, Yeh S, Chang C. Chen J, et al. Nat Rev Urol. 2023 Sep;20(9):560-574. doi: 10.1038/s41585-023-00761-y. Epub 2023 Apr 18. Nat Rev Urol. 2023. PMID: 37072491 Review.
Bladder cancer.
Bischoff CJ, Clark PE. Bischoff CJ, et al. Curr Opin Oncol. 2009 May;21(3):272-7. doi: 10.1097/cco.0b013e328329f184. Curr Opin Oncol. 2009. PMID: 19370808 Review.
Editorial comment.
Galsky MD. Galsky MD. J Urol. 2012 Oct;188(4):1114. doi: 10.1016/j.juro.2012.06.124. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901587 No abstract available.
10,099 results
You have reached the last available page of results. Please see the User Guide for more information.